ESMO Sarcoma and Rare Cancers Congress 2025

The ESMO Sarcoma and Rare Cancers Congress 2025 promises to be an excellent platform for the exchange of cutting-edge research, innovative therapeutic approaches, and collaborative discussions aimed at advancing this field of oncology. Mark your calendars for 20 – 22 March 2025, as we converge in the picturesque city of Lugano, Switzerland, renowned for its scenic beauty and vibrant culture. The ESMO Sarcoma and Rare Cancers Congress 2025 scientific and educational programme will delve into the latest developments in diagnosis, treatment modalities, biology, and molecular classification of rare solid tumours, offering attendees a comprehensive overview of the rapidly evolving landscape in this specialised area.

Topics: sarcoma, rare cancers, oncology, cancer treatment, precision medicine, immunotherapy, soft tissue sarcomas, bone sarcomas, clinical trials, multidisciplinary care, cancer research, pediatric oncology, advanced therapies, targeted therapy, patient care, innovative treatments, rare tumors, genetic profiling, cancer biomarkers, molecular oncology, survivorship, personalised medicine, global oncology, treatment guidelines, research collaborations, healthcare professionals, drug development, radiation oncology, surgical oncology